Navigation Links
China Kanghui Holdings Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
Date:9/6/2011

CHANGZHOU, China, Sept. 6, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that all shareholder resolutions proposed at the Company's 2011 annual general meeting held in Hong Kong on September 5, 2011 were duly adopted. Specifically, the shareholders passed resolutions approving:

  1. Re-election of Mr. Yikang Jiang as a Class A director of the Company.
  2. Re-election of Mr. Jun Du as a Class A director of the Company.
  3. Re-election of Ms. Shuchun Gao as a Class A director of the Company.
  4. Appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ending December 31, 2011.
  5. Amendment of the 2010 Share Incentive Plan to increase share limit.

Pursuant to the resolutions adopted, Mr. Yikang Jiang, Mr. Jun Du and Ms. Shuchun Gao were re-elected as Class A directors of the Company for a term of three years, Ernst & Young Hua Ming was appointed as independent auditor of the Company for the fiscal year ending December 31, 2011, and the share limit of the Company's the 2010 Share Incentive Plan was increased to 15,793,708 ordinary shares, representing approximately 9.29% of the Company's total outstanding shares on a fully diluted basis as of September 5, 2011.

About China Kanghui HoldingsFounded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.Contact:China Kanghui Holdings Investor Relations Department  +1-888-321-2558Asia Bridge Capital LimitedCarene Toh+86-186 1835 6339carene.toh@asiabridgegroup.com
'/>"/>

SOURCE China Kanghui Holdings
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Cord Blood Corporation Announces Participation in Upcoming Investor Conferences
2. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
3. China Botanic Pharmaceutical Enters into Research Cooperation with Key Laboratory of Forest Plant Ecology
4. China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress
5. China Nepstar Chain Drugstore Announces Share Repurchase Program
6. China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results
7. China Nepstar Chain Drugstore Announces Management Change
8. China Medicine Corporation Dismisses Frazer Frost as Auditor
9. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
10. China Contract Research Organization (CRO) Industry Report, 2010-2011
11. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  Licenders is bringing their 100% all-natural lice removal service to ... at 203 13 th Street was specifically chosen to make ... "Our goal is to ease parents, stress and bring their ... children right back to class without skipping a beat. The best ... for the whole family," Licenders President Adie Horowitz states. ...
(Date:12/6/2016)... 6, 2016  "Blood Tests replace Surgical Biopsies. ... The Diagnostic, Monitoring and Screening Test opportunities ... is occurring using in vitro blood testing to ... impressive backing, has announced a single blood test ... faster than the market. New technology that definitively ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader in sealed healthcare ... The MPCNGX is a multi-function, sealed, LED luminaire that meets the needs of everyone ... when it’s needed. , A 2’ x 4’ model features four modes: ...
(Date:12/7/2016)... ... December 07, 2016 , ... OC87 Recovery Diaries ... schizophrenic mother in a unique, personal perspective through animation. , That woman ... addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, lived with schizophrenia. ...
(Date:12/7/2016)... ... 2016 , ... Castle Dermatology Institute is now offering liquid facelifts with ... appearance to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, San Fernando ... to rejuvenate and renew the facial appearance. , Sculptra is a highly effective ...
(Date:12/7/2016)... ... 07, 2016 , ... When it came time to blow out his candles on his 14th ... Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family with ... 30th heart transplant recipient. , “He was playing at home, when we got the ...
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... offering insurance and financial planning services to families and business owners in the ... funds on behalf of the Dallas Fallen Officer Foundation. , Established in 2009 ...
Breaking Medicine News(10 mins):